Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.
Expert encourages cardiologists to continue using conventional drug-eluting stents

Expert encourages cardiologists to continue using conventional drug-eluting stents

New app helps heart patients with drug-eluting stents adhere to medications, study finds

New app helps heart patients with drug-eluting stents adhere to medications, study finds

Stents can be as effective as surgery for many patients with left main coronary artery disease

Stents can be as effective as surgery for many patients with left main coronary artery disease

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

Extended dual antiplatelet therapy after DES implantation increases mortality

Extended dual antiplatelet therapy after DES implantation increases mortality

Patients with multiple narrowed arteries have better outcomes with CABG than with PCI

Patients with multiple narrowed arteries have better outcomes with CABG than with PCI

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announces initiation of ABSORB IV heart stent clinical trial